Is It Time to File an Actos Bladder Cancer Lawsuit?

California Actos Attorney

Do you need to file an Actos bladder cancer injury claim?

If you or a loved one was diagnosed with bladder cancer or other complications after taking Actos, it may be time to consider filing a personal injury claim.

Actos (pioglitazone) was first approved by the U.S. Food and Drug Administration in 1999 to treat Type 2 diabetes in adult patients. The drug quickly became a best-seller for Japanese drug-maker Takeda Pharmaceuticals. In 2010, the drug generated nearly $4.8 billion in revenue alone.

Potential problems with Actos first came to light in September 2010, when the results of an FDA-sponsored research study indicated that patients who used the drug may experience an elevated risk of developing bladder cancer. In June 2011, the FDA issued an updated safety communication warning diabetes patients and health care providers that individuals who used Actos for a year or more were potentially more likely to develop bladder cancer.

That same month, health officials in France and Germany suspended the sale of Actos in those countries after a French research study also indicated an increased risk of bladder cancer among patients who used the drugs. The European Medicines Agency continued to support the use of Actos to treat patients for whom other treatment methods were ineffective or unavailable. In January 2012, the European Commission announced that it had concluded its ongoing safety review of Actos and would continue to support the sale of the drug in Europe.

Since the FDA’s announcement, numerous diabetes patients have filed personal injury claims against Takeda Pharmaceuticals, alleging that Actos caused bladder cancer, heart failure and other serious side effects. If you or a loved one has been taking Actos, you may also need to consider filing a claim. It may be time for you to seek the advice of an experienced Actos injury lawyer if you’ve experienced any of the following:

  • Bladder cancer symptoms, including blood in the urine, painful urination, increased need to urinate, difficulty urinating, lower back pain, abdominal or rectal pain, swelling of the lower legs
  • Heart failure symptoms, including difficulty breathing, chest pain, swelling of the legs and feet, fatigue, difficulty sleeping, inability to exercise

If you’ve had any of these symptoms, you should also consult your physician immediately to determine their cause. If you or a loved one has already been diagnosed with bladder cancer or heart failure after taking Actos, contacting an experienced personal injury attorney should be your next step.

The Actos bladder cancer attorneys at Nadrich & Cohen, LLP are currently investigating claims from concerned patients in all 50 states and we are eager to hear from you. Call us today at 1-800-722-0765 to schedule your no-cost, no-obligation initial case evaluation. All cases are accepted on a contingency basis, meaning there is never a fee unless we recover the maximum amount of compensation you deserve.

The Nadrich & Cohen personal injury blogs are sponsored by Nadrich & Cohen, LLC. This blog features news stories, personal cases and analysis of current events, all of which are intended for illustrative purposes only. Each case is different, and legal authority is constantly changing and evolving. Therefore, nothing on this site should be viewed as a guarantee or prediction of a similar future outcome. The information on this site should not be treated as authoritative, and readers should always consult with legal counsel before making any important legal decisions. Lastly, Nadrich & Cohen, LLC is not responsible for any comments contributed by visitors to this website.

Tags: , , , , , , ,

2 Responses to “Is It Time to File an Actos Bladder Cancer Lawsuit?”

  1. Detra
    12. Feb, 2012 at 7:07 pm #

    I shared this article on Del.icio.us as Actos Bladder Cancer Lawsuit | California Actos Lawyer | Side Effect Actos – Detra :)

  2. Jerry
    12. Feb, 2012 at 10:51 pm #

    Hello I really liked reading your articles.

Leave a Reply

Name (required)

Email (will not be published) (required)

Website